• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床医生与患者主观不良事件评估:基于患者报告结局版通用不良事件术语标准(PRO-CTCAE)。

Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

机构信息

Community Care Teaching and Research Department, Hebei University of Chinese Medicine, Xinshi Road, Shijiazhuang, Hebei Province, China.

Breast Center of the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China.

出版信息

Qual Life Res. 2020 Nov;29(11):3009-3015. doi: 10.1007/s11136-020-02558-7. Epub 2020 Jun 20.

DOI:10.1007/s11136-020-02558-7
PMID:32564293
Abstract

PURPOSE

Adverse events (AEs) assessment by clinicians is a standard practice in a clinical setting. However, studies have found clinicians tend to report fewer AEs, especially subjective AEs. We aimed to explore the difference of subjective AEs assessment between clinicians and patients based on PRO-CTCAE, and to discuss the necessity of incorporating patient into the evaluation of AEs.

METHODS

Between April and July 2019, two different questionnaires with the same subjective AEs were given to patients and clinicians in the Day Chemotherapy ward of Breast Center in the Fourth Hospital of HeBei Medical University. Patients completed a Simplified Chinese version of PRO-CTCAE, including six common subjective AEs of chemotherapy: nausea, vomiting, diarrhea, fatigue, pain, and constipation. Clinicians completed the common terminology criteria for adverse events (CTCAE) with the same AEs. General information of enrolled patients and results from the questionnaires were collected and analyzed.

RESULTS

384 paired questionnaires were collected. Clinicians reported less subjective AEs than patients, and the general agreement between patients and clinicians was poor. When considering the grade difference, we utilize weighted kappa coefficient to analysis, and agreement between patients and clinicians was poor (k < 0.4) regardless of the frequency, the severity and interfering with daily life of AEs, and the most discrepancies were within one point. Patients tended to grade severer than the clinician.

CONCLUSIONS

The results of this study showed that there were differences between clinicians and patients in subjective adverse events evaluation. Patient reporting of symptoms can be used as a supplementary method to incorporate the current approach to monitor subjective AEs, to improve the timeliness and accuracy of clinical evaluation of subjective AEs.

摘要

目的

临床医生对不良事件(AE)的评估是临床实践中的标准做法。然而,研究发现临床医生往往报告较少的 AE,尤其是主观 AE。我们旨在基于 PRO-CTCAE 探讨临床医生和患者在主观 AE 评估方面的差异,并讨论将患者纳入 AE 评估的必要性。

方法

2019 年 4 月至 7 月,在河北医科大学第四医院乳腺中心日间化疗病房,同时向患者和临床医生发放具有相同主观 AE 的两份问卷。患者完成了中文版简化版 PRO-CTCAE,包括化疗的六种常见主观 AE:恶心、呕吐、腹泻、疲劳、疼痛和便秘。临床医生则用相同的 AE 完成通用术语标准不良事件(CTCAE)。收集并分析入组患者的一般信息和问卷结果。

结果

共收集到 384 对问卷。临床医生报告的主观 AE 少于患者,且患者和临床医生之间的总体一致性较差。在考虑等级差异时,我们使用加权 Kappa 系数进行分析,无论 AE 的频率、严重程度和对日常生活的干扰程度如何,患者和临床医生之间的一致性都较差(k<0.4),且最主要的差异仅在 1 级。患者倾向于比临床医生更严重地分级。

结论

这项研究的结果表明,临床医生和患者在主观不良事件评估方面存在差异。患者对症状的报告可作为一种补充方法,纳入当前监测主观 AE 的方法,以提高主观 AE 临床评估的及时性和准确性。

相似文献

1
Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).临床医生与患者主观不良事件评估:基于患者报告结局版通用不良事件术语标准(PRO-CTCAE)。
Qual Life Res. 2020 Nov;29(11):3009-3015. doi: 10.1007/s11136-020-02558-7. Epub 2020 Jun 20.
2
Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.使用完整的患者报告结局版常见不良事件术语标准(PRO-CTCAE)项目库的可行性评估。
Oncologist. 2019 Apr;24(4):e146-e148. doi: 10.1634/theoncologist.2018-0332. Epub 2019 Feb 6.
3
Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.从患者角度评估 III 期转移性去势抵抗性前列腺癌临床试验中的不良事件。
JAMA Oncol. 2020 Feb 1;6(2):e193332. doi: 10.1001/jamaoncol.2019.3332. Epub 2020 Feb 13.
4
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.将儿童和青少年自我报告的症状数据与临床医生报告的不良事件分级进行映射,以改善儿科肿瘤学的护理和研究。
Cancer. 2020 Jan 1;126(1):140-147. doi: 10.1002/cncr.32525. Epub 2019 Sep 25.
5
Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.美国国家癌症研究所患者报告结局通用术语标准不良事件的韩语版的可靠性和有效性。
J Pain Symptom Manage. 2020 May;59(5):1082-1088.e6. doi: 10.1016/j.jpainsymman.2020.01.015. Epub 2020 Feb 8.
6
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.I期临床试验中症状不良事件漏报。
J Natl Cancer Inst. 2021 Aug 2;113(8):980-988. doi: 10.1093/jnci/djab015.
7
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.与标准放疗相比,调强放疗(IMRT)改善患者报告结局:NRG 肿瘤学 RTOG 1203 研究报告。
J Clin Oncol. 2020 May 20;38(15):1685-1692. doi: 10.1200/JCO.19.02381. Epub 2020 Feb 19.
8
Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.患者对乳腺癌辅助化疗相关不良反应的自我评估。
JAMA Oncol. 2016 Apr;2(4):445-52. doi: 10.1001/jamaoncol.2015.4720.
9
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.使用美国国立癌症研究所不良事件通用术语标准的患者与临床医生症状报告:一项基于问卷的研究结果
Lancet Oncol. 2006 Nov;7(11):903-9. doi: 10.1016/S1470-2045(06)70910-X.
10
Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events.整合患者反馈与临床医生报告,以识别肝细胞癌特异性的治疗相关症状性不良事件亚组。
J Patient Rep Outcomes. 2018 Aug 22;2:35. doi: 10.1186/s41687-018-0063-4. eCollection 2017.

引用本文的文献

1
A patient-centered approach to developing and validating a natural language processing model for extracting patient-reported symptoms.一种以患者为中心的方法,用于开发和验证用于提取患者报告症状的自然语言处理模型。
Sci Rep. 2025 Jul 29;15(1):27652. doi: 10.1038/s41598-025-12845-3.
2
Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus.经动脉化疗栓塞联合乐伐替尼加或不加蛋白-1抑制剂治疗伴有门静脉癌栓的肝细胞癌
World J Clin Oncol. 2025 Jun 24;16(6):106798. doi: 10.5306/wjco.v16.i6.106798.
3
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study.
III期CASPIAN研究中广泛期小细胞肺癌患者自我报告的不良事件。
Future Oncol. 2025 May;21(12):1511-1523. doi: 10.1080/14796694.2025.2491297. Epub 2025 May 7.
4
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients.晚期转移性膀胱癌患者中患者与临床医生报告的症状一致性
Cancer Med. 2025 Apr;14(8):e70896. doi: 10.1002/cam4.70896.
5
Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database.生物类似药与风湿病学中使用的原研药的安全性对比:基于欧洲药物警戒数据库的药物警戒分析
J Clin Med. 2025 Feb 28;14(5):1644. doi: 10.3390/jcm14051644.
6
Development and validation of the self-report symptom inventory of immune-related adverse events in patients with lung cancer.肺癌患者免疫相关不良事件自我报告症状量表的编制与验证
Asia Pac J Oncol Nurs. 2024 Oct 12;11(12):100603. doi: 10.1016/j.apjon.2024.100603. eCollection 2024 Dec.
7
A Pilot Study on the Collection of Adverse Event Data from the Patient Using an Electronic Platform in a Cancer Clinical Trial Unit.在癌症临床试验单位使用电子平台从患者收集不良事件数据的一项试点研究。
Drugs Real World Outcomes. 2024 Dec;11(4):725-734. doi: 10.1007/s40801-024-00461-y. Epub 2024 Nov 2.
8
Management of immune check-point inhibitor-associated colitis in patients with advanced metastatic cancers: A review article.晚期转移性癌症患者免疫检查点抑制剂相关性结肠炎的管理:一篇综述文章。
J Family Med Prim Care. 2024 Jul;13(7):2562-2567. doi: 10.4103/jfmpc.jfmpc_1438_23. Epub 2024 Jun 28.
9
Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review.化疗相关性心脏毒性及其在乳腺癌患者中的症状:系统评价。
Syst Rev. 2024 Jun 27;13(1):167. doi: 10.1186/s13643-024-02588-z.
10
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.在新诊断的多发性骨髓瘤且不符合移植条件的患者中,诱导期采用KTd或KRd方案随后进行K方案维持治疗或观察期间的生活质量:随机AGMT 02研究的纵向和横断面分析
EJHaem. 2024 May 17;5(3):494-504. doi: 10.1002/jha2.925. eCollection 2024 Jun.